tailieunhanh - Refractory Inflammatory Bowel Disease in Children

Opportunity: Cancer is the leading cause of death in Canadian children beyond the neonatal period. One in 400 Canadian adults are survivors of childhood cancer, and more than two-thirds experience chronic and/or late-occurring health problems, that often are not clinically apparent until decades after treatment. 10 Non-random molecular or cytogenetic events are found in 50% of childhood cancers, and many types of childhood cancers are associated with congenital anomalies, or family cancer history, suggesting a strong genetic basis for the etiology of cancer in children. All Canadian children with cancer are treated in 17 networked paediatric centres, offering. | Journal of Pediatric Gastroenterology and Nutrition 47 266-272 2008 by European Society for Pediatric Gastroenterology Hepatology and Nutrition and North American Society for Pediatric Gastroenterology Hepatology and Nutrition Refractory Inflammatory Bowel Disease in Children RIBD Working Group M. Oliva-Hemker . Escher ÍD. Moore M. Dubinksy ll. Hildebrand . Koda S. Murch yyB. Sandhu . Seo . Tanzi and B. Warner Johns Hopkins University School of Medicine Baltimore MD Erasmus Medical Center-Sophia Children s Hospital Rotterdam The Netherlands ÍChildren Youth and Women s Health Service Adelaide Australia Cedars-Sinai Medical Center David Geffen School of Medicine at UCLA Los Angeles CA fAstrid Lindgren Children s Hospital Stockholm Sweden IlChild Institute-Hospital das Clinicas Faculty of Medicine of Sao Paulo University Sao Paulo Brazil Warwick Medical School Coventry UK Bristol Royal Hospital for Children Bristol UK ÍÍSeoul National University Children s Hospital Seoul Korea Centro Hospitalario Pereira Rossell Montevideo Uruguay and Washington University School of Medicine St Louis MO Crohn disease CD and ulcerative colitis UC are 2 chronic relapsing inflammatory bowel diseases IBDs of unknown etiology. Approximately 25 of patients are diagnosed by the age of 20 years. Originally the highest incidence rates were reported in northern and Western Europe and in North America. However the gap that previously existed between areas of high and low incidence rates is shrinking because IBD is now being reported with increasing frequency in Africa South America and Asia 1 . In children the incidence of CD appears to have risen above that of UC 1 2 . CD and UC can follow an active and remitting course and their response to therapies can be highly variable. In severe disease inducing and maintaining remission can be difficult. The purpose of this report is to highlight 3 refractory IBD phenotypes for which medical and surgical management can be particularly

• Sức khỏe trẻ em
• Epidemiology
• Sexually Transmitted
• Infections Among
• Military Environment
• Syphilis
• Herpes Simplex Virus
• Reproductive epidemiology
• Modern epidemiology
• Nutritional epidemiology
• Environmental epidemiology
• Clinical epidemiology
• Veterinary epidemiology
• The development
• Veterinary medicine
• The scope of epidemiology
• Describing disease occurrence
• Comparative epidemiology
• Maintenance of infection
• Cancer epidemiology
• Molecular classification
• Genetic epidemiology
• Causal inference
• Cancer incidence
• Molecular epidemiology
• Late blight
• Review on molecular epidemiology
• Molecular epidemiology in relation
• Devastating late blight pathogen
• Fractures in dogs
• Clinical epidemiology of fractures in dogs
• Clinical epidemiology of fractures
• Showing fractures in dogs
• Lecture Introduction to Epidemiology
• Introduction to Epidemiology
• Infectious disease epidemiology
• Disease prevention and control
• Disease screening
• Epidemics investigation
• public health
• healthcare
• epidemiology principles
• analytic epidemiology
• Health Practice
• Principles of Epidemiology
• Ecologic studies
• Social epidemiology
• Using secondary data
• Improve study accuracy
• C ausal diagrams
• Design strategies
• Questionnaire in clinical epidemiology
• Survey sheet for medica
• Medical survey layout
• Medical questionnaire development
• Epidemiology of Dermatomycoses
• Infections Observed
• Humans and Animals
• Great Concern
• MRSA Epidemiology
• Emphasis on MLST
• Epidemiology in gynecological diseases
• Gynecological diseases
• Basic epidemiology
• Models of causation
• Environmental factors
• Childhood Obesity
• Epidemiology and Risk Factors
• Epidemiological
• Clinical Aspects
• Developing Country
• Early Infant
• Medical device regulation
• Medical device epidemiology
• Active surveillance
• Necessary conditions
• Medical device nomenclature
• Data sources
• effective surveillance
• Epidemiology Cluster
• Data Analysis
• Biology Cluster
• Carcinogenesis Cluster
• Prevention Cluster
• Descriptive Studies
• Disease Registers
• Cohort Studies
• Intervention Trials
• Epidemiological FieldWork
• Epidemiological Studies
• Population Based Studies
• Risk Factors
• Hepatocellular Carcinoma
• Surgical Treatment
• Liver Metastases
• Evidence based medicine
• Systematic reviews
• Health economics
• Health improvement
• Demonstrating association
• Observational studies
• Design considerations
• Clinical trials
• Statistical modeling
• Mathematical modeling
• Clinical gastroenterology
• The changing epidemiology of IBD
• The pathogenesis
• The mesalamine based therapies
• The adult patient
• Journal of Science and Technology
• Complex environment representation in epidemiology ABM
• Application on H5N1 propagation
• Individual based epidemiological model
• Climate change
• Climate change and epidemiology
• Human parasitosis in Egypt
• Future of such parasitic diseases
• Scenarios for climate change
• Ovine brucellosis
• Caprine brucellosis
• Serodiagnosis and epidemiology
• Brucellosis in sheep
• Goats and its serodiagnosis
• Infectious bursal disease
• Broiler chickens
• Broiler chickens in Haryana
• Retrospective study on epidemiology
• IBD outbreaks
• BMC Pediatrics
• Rotavirus causing diarrhea
• Children hospitals
• Enzyme Linked Immunosorbent Assay
• Decision making
• Lay epidemiology
• Risk evaluation
• Patient provider communication
• Vaccine safety concerns
• Heterologous immunity